Compare Bandhan Healthcare Fund vs SBI Healthcare Opportunities Fund
Bandhan Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.78
1.99
NAV
₹10.41
₹548.45
Fund Started
10 Nov 2025
04 Jun 1999
Fund Size
₹326.54 Cr
₹5870.00 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
7.37%
3 Year
-
20.57%
5 Year
-
16.17%
Equity
93.55%
95.53%
Cash
6.41%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.74% |
Cipla Ltd. | 6.18% |
Apollo Hospitals Enterprise Ltd. | 5.75% |
Max Healthcare Institute Ltd. | 5.27% |
Lupin Ltd. | 4.35% |
Divi's Laboratories Ltd. | 4.27% |
Shilpa Medicare Ltd. | 4.17% |
Aurobindo Pharma Ltd. | 4.10% |
Dr. Reddy's Laboratories Ltd. | 3.78% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.39% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 Nov 2025
04 Jun 1999
